diclofenac has been researched along with hydrogen sulfide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caliendo, G; Cirino, G; Fiorucci, S; Santagada, V; Wallace, JL | 1 |
Bhatia, M; Li, L; Moore, PK; Sidhapuriwala, J; Sparatore, A | 1 |
Bhatia, M; Moore, PK; Sidhapuriwala, JN; Sparatore, A | 1 |
Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G; Sparatore, A; Tazzari, V | 1 |
Baskar, R; Del Soldato, P; Moore, PK; Sparatore, A | 1 |
Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A | 1 |
Del Soldato, P; Giustarini, D; Rossi, R; Santus, G; Sparatore, A | 1 |
Olas, B | 1 |
2 review(s) available for diclofenac and hydrogen sulfide
Article | Year |
---|---|
Therapeutic potential of new hydrogen sulfide-releasing hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Humans; Hydrogen Sulfide; Inflammation; Latanoprost; Levodopa; Prodrugs; Prostaglandins F, Synthetic | 2011 |
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
6 other study(ies) available for diclofenac and hydrogen sulfide
Article | Year |
---|---|
Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Drug Design; Gastric Acid; Heterocyclic Compounds, 1-Ring; Humans; Hydrogen Sulfide; Male; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Stomach | 2007 |
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hindlimb; Hydrogen Sulfide; Injections; Male; Neutrophils; Nitrates; Nitrites; Peroxidase; Rats; Rats, Wistar; Thiones | 2007 |
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ceruletide; Diclofenac; Disease Models, Animal; Hydrogen Sulfide; Lung; Lung Injury; Male; Mice; Pancreatitis, Acute Necrotizing; Thiones | 2008 |
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart.
Topics: Animals; Creatine Kinase; Diclofenac; Epoprostenol; Glutathione; Glyburide; Heart; Hydrogen Sulfide; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Sulfides; Thiones; Ventricular Function, Left | 2008 |
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Diclofenac; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Fluorescent Dyes; Hydrogen Sulfide; In Vitro Techniques; Indoles; Mitotic Index; Myocytes, Smooth Muscle; Rats; Thiones | 2008 |
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Diclofenac; Female; Humans; Hydrogen Sulfide; I-kappa B Kinase; Mice; NF-kappa B; Osteoclasts; Osteolysis; Sulfones; Thiones | 2012 |